Thermopylae Holdings Ltd., 10% Owner at AbCellera Biologics Inc. (ABCL), bought 129,090 shares at $7.50 ($968K) on 2022-06-06, disclosed to the SEC on 2022-06-08.
Open-market purchase of $968k ABCL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 64,545 | $484K | 50.0% |
| 2 | $7.50 | 64,545 | $484K | 50.0% |
| Total | $7.50 avg | 129,090 | $968K | 100% |
| Filing → |
| ABCL | BUY | 2025-03-11 | $1.5M | — | Filing → |
| ABCL | BUY | 2024-08-29 | $1.5M | — | Filing → |
| ABCL | BUY | 2023-05-26 | $2.0M | — | Filing → |